Search research articles
Contact Us
Filters
Showing results (131-140 of 231) with videos related to
Page
of 24
Sort By:
American Journal of Respiratory Cell and Molecular Biology
|
February 28, 2003
Characterization of a lanosterol 14 alpha-demethylase from Pneumocystis carinii
Ian J Morales, Pawan K Vohra, Veenu Puri, et al.
Antimicrobial Agents and Chemotherapy
|
April 16, 2014
Pneumocystis jirovecii Rtt109, a novel drug target for Pneumocystis pneumonia in immunosuppressed humans
Jayme L Dahlin, Theodore Kottom, Junhong Han, et al.
Drugs in R&D
|
August 6, 2024
Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2)
Theodore J Kottom, Kimberly E Stelzig, Madeline R Pellegrino, et al.
Respiratory Research
|
May 31, 2023
Dysbiosis of the intestinal fungal microbiota increases lung resident group 2 innate lymphoid cells and is associated with enhanced asthma severity in mice and humans
Amjad N Kanj, Theodore J Kottom, Kyle J Schaefbauer, et al.
Cancer Medicine
|
June 22, 2021
Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction-based diagnosis in patients receiving bendamustine
Mikhaila L Rice, Jason N Barreto, Carrie A Thompson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 19, 2020
IPF pathogenesis is dependent upon TGFβ induction of IGF-1
Danielle M Hernandez, Jeong-Han Kang, Malay Choudhury, et al.
Clinical Transplantation
|
May 17, 2023
Risk factors and outcomes of Pneumocystis pneumonia in solid organ transplant recipients: Impact of posttransplant lymphoproliferative disorder
Zachary A Yetmar, Dustin Duffy, Byron H Smith, et al.
European Journal of Pharmacology
|
June 4, 2017
Phenylpyrrolidine structural mimics of pirfenidone lacking antifibrotic activity: A new tool for mechanism of action studies
Andrew J Haak, Megan A Girtman, Mohamed F Ali, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
October 4, 2005
Surfactant protein D enhances Pneumocystis infection in immune-suppressed mice
Zvezdana Vuk-Pavlovic, Eun K Mo, Crystal R Icenhour, et al.
Annals of the American Thoracic Society
|
August 23, 2014
Pneumonia. Treatment and diagnosis
Joshua T Mattila, Michael J Fine, Andrew H Limper, et al.
Page
of 24
Search research articles
Search
Showing results (131-140 of 231) with videos related to
Sort By:
Page
of 24
American Journal of Respiratory Cell and Molecular Biology
|
February 28, 2003
Characterization of a lanosterol 14 alpha-demethylase from Pneumocystis carinii
Ian J Morales, Pawan K Vohra, Veenu Puri, et al.
Antimicrobial Agents and Chemotherapy
|
April 16, 2014
Pneumocystis jirovecii Rtt109, a novel drug target for Pneumocystis pneumonia in immunosuppressed humans
Jayme L Dahlin, Theodore Kottom, Junhong Han, et al.
Drugs in R&D
|
August 6, 2024
Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2)
Theodore J Kottom, Kimberly E Stelzig, Madeline R Pellegrino, et al.
Respiratory Research
|
May 31, 2023
Dysbiosis of the intestinal fungal microbiota increases lung resident group 2 innate lymphoid cells and is associated with enhanced asthma severity in mice and humans
Amjad N Kanj, Theodore J Kottom, Kyle J Schaefbauer, et al.
Cancer Medicine
|
June 22, 2021
Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction-based diagnosis in patients receiving bendamustine
Mikhaila L Rice, Jason N Barreto, Carrie A Thompson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 19, 2020
IPF pathogenesis is dependent upon TGFβ induction of IGF-1
Danielle M Hernandez, Jeong-Han Kang, Malay Choudhury, et al.
Clinical Transplantation
|
May 17, 2023
Risk factors and outcomes of Pneumocystis pneumonia in solid organ transplant recipients: Impact of posttransplant lymphoproliferative disorder
Zachary A Yetmar, Dustin Duffy, Byron H Smith, et al.
European Journal of Pharmacology
|
June 4, 2017
Phenylpyrrolidine structural mimics of pirfenidone lacking antifibrotic activity: A new tool for mechanism of action studies
Andrew J Haak, Megan A Girtman, Mohamed F Ali, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
October 4, 2005
Surfactant protein D enhances Pneumocystis infection in immune-suppressed mice
Zvezdana Vuk-Pavlovic, Eun K Mo, Crystal R Icenhour, et al.
Annals of the American Thoracic Society
|
August 23, 2014
Pneumonia. Treatment and diagnosis
Joshua T Mattila, Michael J Fine, Andrew H Limper, et al.
Page
of 24